Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dystrophies, Landouzy-Dejerine”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Not applicableLooking for participantsNCT06079567
What this trial is testing

An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression

Who this might be right for
Facioscapulohumeral Muscular Dystrophy Type 2
Centre Hospitalier Universitaire de Nice 50
Not applicableLooking for participantsNCT07409142
What this trial is testing

BetterLife FSHD: A Patient-driven Health and Research Platform

Who this might be right for
FSHFSH Muscular DystrophyFSHD - Facioscapulohumeral Muscular Dystrophy+8 more
FSHD Society 5,000
Large-scale testing (Phase 3)Ended earlyNCT05397470
What this trial is testing

Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
Fulcrum Therapeutics 260
Not applicableStudy completedNCT00004769
What this trial is testing

Study of Muscle Wasting and Altered Metabolism in Patients With Myotonic Dystrophy

Who this might be right for
Myotonic Muscular Dystrophy
University of Rochester 130
Not applicableEnrolling By InvitationNCT07072676
What this trial is testing

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

Who this might be right for
Inclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more
LMU Klinikum 30
Testing effectiveness (Phase 2)Study completedNCT02603562
What this trial is testing

Evaluate Safety and Biological Activity of ATYR1940 in Participants With Early Onset Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Facioscapulohumeral Muscular Dystrophy (FSHD)
aTyr Pharma, Inc. 8
Not applicableStudy completedNCT05239520
What this trial is testing

Understanding Control and Mechanisms of Shoulder Instability in FSHD

Who this might be right for
Shoulder PainNeuromuscular DiseasesShoulder Injuries+2 more
University of Liverpool 14
Not applicableStudy completedNCT00821548
What this trial is testing

Electrostimulation of Shoulder Girdle and Quadriceps Muscles in Facioscapulohumeral Muscular Dystrophy Patients

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Centre Hospitalier Universitaire de Nice 9
Not applicableStudy completedNCT02413190
What this trial is testing

Bone Health in Facioscapulohumeral Muscular Dystrophy

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
Hugo W. Moser Research Institute at Kennedy Krieger, Inc. 94
Not applicableActive Not RecruitingNCT03458832
What this trial is testing

Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
University of Kansas Medical Center 324
Not applicableEnrolling By InvitationNCT07164937
What this trial is testing

Imaging and Gait Analysis in FSHD Patients

Who this might be right for
FSHD - Facioscapulohumeral Muscular Dystrophy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 40
Not applicableStudy completedNCT06425445
What this trial is testing

Quantitative Assessment of Orofacial Muscle Function in FSHD

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
University of Mons 22
Not applicableUnknownNCT05295277
What this trial is testing

Validation of Optical Genome Mapping for the Identification of Constitutional Genomic Variants in a Postnatal Cohort

Who this might be right for
Developmental DisabilityIntellectual DisabilityAutism Spectrum Disorder+3 more
Bionano Genomics 1,000
Not applicableUnknownNCT06378203
What this trial is testing

Rehabilitation in Muscular Dystrophies From the Hospital Facility to the Home: Pilot Project [RIMUDI]

Who this might be right for
Muscular DystrophiesLimb Girdle Muscular DystrophyFacio-Scapulo-Humeral Dystrophy+1 more
IRCCS Eugenio Medea 10
Not applicableLooking for participantsNCT07136844
What this trial is testing

Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology

Who this might be right for
Neuromuscular DiseasesObesity (Disorder)Myotonic Dystrophy 1+9 more
Centre Hospitalier Universitaire de Liege 300
Not applicableLooking for participantsNCT06600308
What this trial is testing

Walking ANalysis Interest in Persons wiTh facioscapulohumEral Muscular Dystrophies

Who this might be right for
Facioscapulohumeral Dystrophy
Centre Hospitalier Universitaire Dijon 60
Not applicableUnknownNCT05902884
What this trial is testing

New Biomarkers in Facioscapulohumeral Muscular Dystrophy, Multispectral Optoacoustic Tomography.

Who this might be right for
FSHD
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 20
Not applicableStudy completedNCT01596803
What this trial is testing

Effects Antioxidants Supplementation on Muscular Function Patients Facioscapulohumeral Dystrophy (FSHD)

Who this might be right for
Facioscapulohumeral Muscular Dystrophy
University Hospital, Montpellier 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT06547216
What this trial is testing

Phase 2 Open-label Extension Study of AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)

Who this might be right for
FSHDFSHD1FSHD2+24 more
Avidity Biosciences, Inc. 84
Testing effectiveness (Phase 2)Ended earlyNCT04004000
What this trial is testing

Evaluation of Safety, Tolerability, and Changes in Biomarker and Clinical Outcome Assessments of Losmapimod for FSHD1 With Extension

Who this might be right for
Facioscapulohumeral Muscular Dystrophy 1
Fulcrum Therapeutics 14
Next Page